CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
Project Number3U01MD018308-01S1
Contact PI/Project LeaderLAURENT, LOUISE CHANG Other PIs
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN DIEGO
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Cases of COVID-19 infection in San Diego have persistently remained high in the county’s central and southern
communities near the US/Mexico border, home to primarily Latino residents who have been one of the ethnic
minority communities most impacted by COVID-19. To address this, our Phase I RADx-UP project partnered
with San Ysidro Health (SYH), a federally qualified health center, and the Global Action Research Center (Global
ARC), a social change organization, to co-create and demonstrate the impact of a PCR-based COVID-19 testing
program in San Ysidro. To date, we have administered approximately 15,000 PCR tests for >10,000 community
members (92% Latino) and received requests from SYH to scale-out the testing program to additional primary
care clinic sites. Responsive to RFA-OD-22-006, we will continue working with our community (Global ARC) and
clinical (SYH) partners to refine, specify, implement, and evaluate an implementation strategy bundle that
optimizes COVID-19 testing, expanding beyond current PCR testing to focus on FDA-authorized COVID-19 rapid
antigen testing. Use of self-administered rapid antigen tests will allow participants to build capacity to self-test
and use health information technology to access additional clinic services. Based on initial implementation
mapping with the project’s established Community and Scientific Advisory Board, three implementation
strategies were prioritized to accelerate sustained uptake of rapid COVID-19 testing. These three strategies
include: (1) current, walk-up onsite free testing; (2) promotores-led COVID-19 test counseling and preventive
care reminders; (3) vending machines that dispense FDA-authorized self-testing kits. Our primary objectives are
to: 1) refine and operationalize our multi-component implementation strategy bundle and a related set of
measures of success for rapid FDA- authorized COVID-19 testing and 2) implement and evaluate impact of our
innovative, multilevel, and multicomponent implementation strategy bundle to optimize COVID-19 rapid testing
among underserved, Latino communities using a roll-out implementation optimization study design across four
clinics over 18 months. The COVID-19 pandemic has underscored the urgent and essential need to engage
invested community parties continuously and meaningfully in public health research to reduce health disparities.
This proposal is well-positioned to provide a set of strategies and measures of success that can be used in
settings serving underserved communities while maintaining flexibility to adjust to the changing COVID-19
landscape.
Public Health Relevance Statement
PROJECT NARRATIVE
In our Phase I RADx-UP project, UC San Diego partnered with San Ysidro Health, a federally qualified health
center, and the Global Action Research Center, a social change organization, to co-create and demonstrate
the impact of a PCR-based COVID-19 testing program in San Ysidro, one of the most impacted areas from
COVID-19 in San Diego County. To date, we have tested >10,000 community members (92% Latino) and
received requests to scale-out the testing program to additional primary care clinic sites. In this Phase III
proposal, we will extend work with our Phase I community and clinical partners to refine, specify, implement,
and evaluate an implementation strategy bundle that optimizes COVID-19 testing, expanding beyond current
PCR testing to FDA-authorized COVID-19 rapid antigen testing.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AccelerationAction ResearchAddressAdministratorAdoptionAreaAuthorization documentationCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 testCOVID-19 testingCaliforniaClinicClinicalCommunitiesCommunity ParticipationCounselingCountyDiagnostic Reagent KitsDisparityFDA approvedFederally Qualified Health CenterGenerationsGoalsHealthHomeHumanIncidenceInstitutionInvestmentsKnowledgeLatinoLearningLinguisticsMapsMeasuresMethodsMexicoModelingOrganizational ChangeOutcomeParticipantPhasePopulationPositioning AttributePractical Robust Implementation and Sustainability ModelPreparationPreventive careProtocols documentationProviderPublic HealthRADx Underserved PopulationsReduce health disparitiesResearchResearch DesignResearch PersonnelSARS-CoV-2 infectionSelf AdministrationServicesSiteSocial ChangeSpecific qualifier valueTestingTheory of ChangeTrustWalkingWorkantigen testauthoritycare systemscommunity centercommunity organizationsethnic minorityevaluation/testingexperienceflexibilityhealth disparityhealth information technologyimplementation designimplementation evaluationimplementation measuresimplementation scienceimplementation strategyinnovationmemberminority communitiespandemic diseasepractical applicationprimary care clinicprimary outcomeprogramsprototypepublic health researchrapid testrapid testingresponsesafety netsecondary outcomeself testingsuccesstesting uptaketransmission processunderserved communityuptake
National Institute on Minority Health and Health Disparities
CFDA Code
310
DUNS Number
804355790
UEI
UYTTZT6G9DT1
Project Start Date
01-November-2022
Project End Date
31-October-2025
Budget Start Date
01-November-2023
Budget End Date
31-October-2025
Project Funding Information for 2023
Total Funding
$1,013,772
Direct Costs
$751,763
Indirect Costs
$262,009
Year
Funding IC
FY Total Cost by IC
2023
NIH Office of the Director
$1,013,772
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 3U01MD018308-01S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01MD018308-01S1
Patents
No Patents information available for 3U01MD018308-01S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01MD018308-01S1
Clinical Studies
No Clinical Studies information available for 3U01MD018308-01S1
News and More
Related News Releases
No news release information available for 3U01MD018308-01S1
History
No Historical information available for 3U01MD018308-01S1
Similar Projects
No Similar Projects information available for 3U01MD018308-01S1